BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Michele Reni, Gianpaolo Balzano, Giuseppe Aprile, Stefano Cereda, Paolo Passoni, Alessandro Zerbi, Maria Chiara Tronconi, Carlo Milandri, Piercarlo Saletti, Alessia Rognone, Clara Fugazza, Alessandro Magli, Nadia Di Muzio, Valerio Di Carlo, Eugenio Villa. Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II TrialAnnals of Surgical Oncology 2012; 19(7): 2256 doi: 10.1245/s10434-011-2205-2
2
Kenjiro Kimura, Ryosuke Amano, Bunzo Nakata, Sadaaki Yamazoe, Keiichiro Hirata, Akihiro Murata, Kotaro Miura, Kohei Nishio, Toshiki Hirakawa, Masaichi Ohira, Kosei Hirakawa. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinomaWorld Journal of Surgical Oncology 2014; 12(1): 360 doi: 10.1186/1477-7819-12-360
3
Fuyuhiko Motoi, Kazuyuki Ishida, Fumiyoshi Fujishima, Shigeru Ottomo, Masaya Oikawa, Takaho Okada, Hiromune Shimamura, Shinichi Takemura, Fuminori Ono, Masanori Akada, Kei Nakagawa, Yu Katayose, Shinichi Egawa, Michiaki Unno. Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 TrialAnnals of Surgical Oncology 2013; 20(12): 3794 doi: 10.1245/s10434-013-3129-9
4
Mukesh Verma. Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and EpidemiologyCancers 2010; 2(4): 1830 doi: 10.3390/cancers2041830
5
Asma Sultana, Trevor Cox, Paula Ghaneh, John P. Neoptolemos. Early Gastrointestinal CancersRecent Results in Cancer Research 2012; 196: 65 doi: 10.1007/978-3-642-31629-6_5
6
M. Mura Assifi, Xuyang Lu, Guido Eibl, Howard A. Reber, Gang Li, O. Joe Hines. Neoadjuvant therapy in pancreatic adenocarcinoma: A meta-analysis of phase II trialsSurgery 2011; 150(3): 466 doi: 10.1016/j.surg.2011.07.006
7
Lucia Lombardi, Michele Troiano, Nicola Silvestris, Luciano Nanni, Tiziana Pia Latiano, Gabriele Di Maggio, Saverio Cinieri, Pierluigi Di Sebastiano, Giuseppe Colucci, Evaristo Maiello. Combined modality treatments in pancreatic cancerExpert Opinion on Therapeutic Targets 2012; 16(sup2): S71 doi: 10.1517/14728222.2012.662959
8
Fuyuhiko Motoi, Michiaki Unno, Hidenori Takahashi, Takaho Okada, Keita Wada, Masayuki Sho, Hiroaki Nagano, Ippei Matsumoto, Sohei Satoi, Yoshiaki Murakami, Masashi Kishiwada, Goro Honda, Hisafumi Kinoshita, Hideo Baba, Shoichi Hishinuma, Minoru Kitago, Hidehiro Tajima, Hiroyuki Shinchi, Hiroshi Takamori, Tomoo Kosuge, Hiroki Yamaue, Tadahiro Takada. Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic SurgeryJournal of Hepato-Biliary-Pancreatic Sciences 2014; 21(2): 148 doi: 10.1002/jhbp.15